News on in vitro diagnostics for gastrointestinal disease.
Microba currently offers a direct-to-consumer gut microbiome profile product and plans to release additional products for clinical and research use cases.
Two research groups have cultured and sequenced microbes in fecal samples from healthy volunteers, producing new reference genomes for hundreds of species.
The firm lowered topline and non-GAAP earnings per share guidance for fiscal 2019.
A new analysis found kidney disease-related pathogenic or likely pathogenic variants in exomes for roughly 9 percent of individuals with chronic kidney disease.
Research suggests gut microbe representation, abundance, and function may provide clues for diagnosing Crohn's disease, ulcerative colitis, and irritable bowel syndrome.
